Cargando…

Hyperuricaemia, gout and allopurinol in the CKD Queensland registry

INTRODUCTION: There is scant data on the role of hyperuricaemia, gout and allopurinol treatment in chronic kidney disease (CKD). Therefore, our aim is to investigate the possible associations between hyperuricaemia, gout, prescription of allopurinol and renal outcomes in patients with CKD. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jeyaruban, A., Hoy, W., Cameron, A., Healy, H., Wang, Z., Zhang, J., Mallett, A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8192410/ https://www.ncbi.nlm.nih.gov/pubmed/33439469 http://dx.doi.org/10.1007/s40620-020-00937-4

Ejemplares similares

Impact of cardiovascular events on mortality and progression of renal dysfunction in a Queensland CKD cohort
por: Jeyaruban, Andrew, et al.
Publicado: (2020)

CKD.QLD: establishment of a chronic kidney disease [CKD] registry in Queensland, Australia
por: Venuthurupalli, Sree K., et al.
Publicado: (2017)

Chronic Kidney Disease, Queensland (CKD.QLD) Registry: Management of CKD With Telenephrology
por: Venuthurupalli, Sree K., et al.
Publicado: (2018)

Frequency and Consequences of Acute Kidney Injury in Patients With CKD: A Registry Study in Queensland Australia
por: Zhang, Jianzhen, et al.
Publicado: (2019)

CKD.QLD: chronic kidney disease surveillance and research in Queensland, Australia
por: Venuthurupalli, Sree K., et al.
Publicado: (2012)

The first metatarsophalangeal joint in gout and asymptomatic hyperuricaemia
por: Stewart, Sarah, et al.
Publicado: (2015)

Gout and hyperuricaemia: modifiable cardiovascular risk factors?
por: Burnier, Michel
Publicado: (2023)

The Ckd. Qld fabRy Epidemiology (aCQuiRE) study protocol: identifying the prevalence of Fabry disease amongst patients with kidney disease in Queensland, Australia
por: Mallett, Andrew, et al.
Publicado: (2020)

The Impact of Anaemia on Outcomes, Admissions, and Costs in Patients with Chronic Kidney Disease in Two Public Nephrology Practices in Queensland: A CKD.QLD Registry Study
por: Zhang, Jianzhen, et al.
Publicado: (2023)

Diabetes and gout: efficacy and safety of febuxostat and allopurinol
por: Becker, M A, et al.
Publicado: (2013)

Incident gout and erectile dysfunction: is hyperuricaemia the elephant in the room?
por: Abhishek, Abhishek, et al.
Publicado: (2017)

Gout, Hyperuricaemia and Crystal-Associated Disease Network (G-CAN) common language definition of gout
por: Murdoch, Rachel, et al.
Publicado: (2021)

Hospitalizations Among Adults With CKD in Public Renal Specialty Practices: A Retrospective Study From Queensland, Australia
por: Diwan, Vishal, et al.
Publicado: (2023)

Impact of comorbidities on gout and hyperuricaemia: an update on prevalence and treatment options
por: Bardin, Thomas, et al.
Publicado: (2017)

Risk of dementia in gout and hyperuricaemia: a meta-analysis of cohort studies
por: Pan, Shu-Yue, et al.
Publicado: (2021)

Hyperthyroid and Hypothyroid Status Was Strongly Associated with Gout and Weakly Associated with Hyperuricaemia
por: See, Lai-Chu, et al.
Publicado: (2014)

The Management of Hyperuricaemia
por: Bayliss, Richard, et al.
Publicado: (1984)

Cardiovascular risk associated with allopurinol or benzbromarone treatment in patients with gout
por: Eun, Yeonghee, et al.
Publicado: (2022)

Musculoskeletal ultrasound features-based scoring system can evaluate the severity of gout and asymptomatic hyperuricaemia
por: Liu, Fengjing, et al.
Publicado: (2021)

Gout, flares, and allopurinol use: a population-based study
por: Proudman, Charlotte, et al.
Publicado: (2019)

Protocol and establishment of a Queensland renal biopsy registry in Australia
por: Burke, Joseph Patrick, et al.
Publicado: (2020)

Protocol of the Febuxostat versus Allopurinol Streamlined Trial (FAST): a large prospective, randomised, open, blinded endpoint study comparing the cardiovascular safety of allopurinol and febuxostat in the management of symptomatic hyperuricaemia
por: MacDonald, Thomas M, et al.
Publicado: (2014)

Allopurinol use and the risk of acute cardiovascular events in patients with gout and diabetes
por: Singh, Jasvinder A., et al.
Publicado: (2017)

Rationale, design, demographics and baseline characteristics of the randomized, controlled, Phase 2b SAPPHIRE study of verinurad plus allopurinol in patients with chronic kidney disease and hyperuricaemia
por: Heerspink, Hiddo J L, et al.
Publicado: (2021)

African American patients with gout: efficacy and safety of febuxostat vs allopurinol
por: Wells, Alvin F, et al.
Publicado: (2012)

Cardiovascular risk associated with allopurinol vs. benzbromarone in patients with gout
por: Kang, Eun Ha, et al.
Publicado: (2021)

Characteristics of the first metatarsophalangeal joint in gout and asymptomatic hyperuricaemia: a cross-sectional observational study
por: Stewart, Sarah, et al.
Publicado: (2015)

Genome-wide association study revealed novel loci which aggravate asymptomatic hyperuricaemia into gout
por: Kawamura, Yusuke, et al.
Publicado: (2019)

Sex differences in response to allopurinol and benzbromarone in gout: a retrospective cohort study
por: Veenstra, Frouwke, et al.
Publicado: (2021)

Anti-Gout Effects of the Medicinal Fungus Phellinus igniarius in Hyperuricaemia and Acute Gouty Arthritis Rat Models
por: Li, Hongxing, et al.
Publicado: (2022)

Cardiovascular safety of febuxostat and allopurinol in patients with gout: A meta-analysis
por: Guan, Xudong, et al.
Publicado: (2022)

Is coffee consumption associated with a lower risk of hyperuricaemia or gout? A systematic review and meta-analysis
por: Zhang, Yi, et al.
Publicado: (2016)

Allopurinol Lowers Serum Urate but Does Not Reduce Oxidative Stress in CKD
por: Sun, Mingyao, et al.
Publicado: (2022)

Transdermal delivery of allopurinol-loaded nanostructured lipid carrier in the treatment of gout
por: Ali, Zakir, et al.
Publicado: (2022)

Lesinurad in combination with allopurinol: results of a phase 2, randomised, double-blind study in patients with gout with an inadequate response to allopurinol
por: Perez-Ruiz, Fernando, et al.
Publicado: (2016)

Blood pressure management in hypertensive people with non-dialysis chronic kidney disease in Queensland, Australia
por: Zhang, Jianzhen, et al.
Publicado: (2019)

CKD Screening and Surveillance in Australia: Past, Present, and Future
por: Venuthurupalli, Sree K., et al.
Publicado: (2017)

Correction: Is coffee consumption associated with a lower risk of hyperuricaemia or gout? A systematic review and meta-analysis
Publicado: (2016)

Diagnosis and treatment for hyperuricaemia and gout: a protocol for a systematic review of clinical practice guidelines and consensus statements
por: Li, Qianrui, et al.
Publicado: (2017)

The Effect of Lesinurad in Combination With Allopurinol on Serum Uric Acid Levels in Patients With Gout
por: Baumgartner, Scott, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_b2pr28rbu2oei212357maoh29o